Sensor Test Indicates Early Inflammation in Oral Cavity
|
By LabMedica International staff writers Posted on 28 Aug 2017 |
|
Image: Researchers have developed a rapid test using a specialized chewing gum that enables the tongue to detect oral inflammation (Photo courtesy of Julius-Maximilians-University Würzburg).
Researchers have developed a novel rapid test using chewing gum and the tongue as a 24/7 detector, potentially providing a diagnostic device that could be used by nearly “anyone, anywhere, anytime”. Their first such gum was successful in using saliva samples to identify patients with dental implants who had early-stage inflammation due to bacterial infection. Expanding this platform technology to other diseases could also provide more efficient screening of large populations.
Dental implants occasionally entail complications: in the years after receiving an implant 6-15% of patients develop an inflammatory response caused by bacteria, in the worst case destroying the soft tissue and bone around the implant. When the new test will be available (planned for in 2-3 years), patients would benefit from a simple, quick, and affordable method to assess whether they carry such bacteria.
The gum test was developed by a pharmaceutical research team at Julius-Maximilians-University Würzburg (JMU, Wurzburg, Germany) to provide early detection aimed at preventing serious complications. "Anyone can use this new diagnostic tool anywhere and anytime without any technical equipment," said Prof. Lorenz Meinel of JMU, who co-led the development with Dr. Jennifer Ritzer. Initial proof-of-principle studies using saliva of patients were conducted at Merli Dental Clinic in Rimini.
The scientific background: In the presence of inflammatory conditions, specific protein-degrading enzymes (matrix metalloproteinases) are activated in the mouth. While chewing the gum, these enzymes also rapidly break down the special ingredient in gum: peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. When the peptide is cleaved, the bitter tasting substance is released and detected by the tongue. Patients can then visit their dentist who confirms the diagnosis and treats the disease.
Chewing gum rapid tests for other medical applications are presently under development. "We hope to be able to diagnose other diseases with our “anyone, anywhere, anytime” diagnostics to identify and address these diseases as early as possible," said Prof. Meinel.
The study, by Ritzer J et al, was published August 15, 2017, in the journal Nature Communications.
Related Links:
Julius-Maximilians-University Würzburg
Dental implants occasionally entail complications: in the years after receiving an implant 6-15% of patients develop an inflammatory response caused by bacteria, in the worst case destroying the soft tissue and bone around the implant. When the new test will be available (planned for in 2-3 years), patients would benefit from a simple, quick, and affordable method to assess whether they carry such bacteria.
The gum test was developed by a pharmaceutical research team at Julius-Maximilians-University Würzburg (JMU, Wurzburg, Germany) to provide early detection aimed at preventing serious complications. "Anyone can use this new diagnostic tool anywhere and anytime without any technical equipment," said Prof. Lorenz Meinel of JMU, who co-led the development with Dr. Jennifer Ritzer. Initial proof-of-principle studies using saliva of patients were conducted at Merli Dental Clinic in Rimini.
The scientific background: In the presence of inflammatory conditions, specific protein-degrading enzymes (matrix metalloproteinases) are activated in the mouth. While chewing the gum, these enzymes also rapidly break down the special ingredient in gum: peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. When the peptide is cleaved, the bitter tasting substance is released and detected by the tongue. Patients can then visit their dentist who confirms the diagnosis and treats the disease.
Chewing gum rapid tests for other medical applications are presently under development. "We hope to be able to diagnose other diseases with our “anyone, anywhere, anytime” diagnostics to identify and address these diseases as early as possible," said Prof. Meinel.
The study, by Ritzer J et al, was published August 15, 2017, in the journal Nature Communications.
Related Links:
Julius-Maximilians-University Würzburg
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage
Rapid and accurate testing is crucial in the fight against Hepatitis C. Hepatitis C blood testing determines whether someone has been infected with the Hepatitis C virus. Having regular access to testing... Read more
Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
Stroke is the primary cause of disability globally and ranks as the second leading cause of death. However, timely early intervention can prevent severe outcomes. Most strokes are ischemic, resulting from... Read more
 (1)_1.jpg "Image: Ultrasound image of micro-histotripsy liberation of biomarkers in a tumor (Photo courtesy of Joy Wang and Pradyumna Kedarisetti)"){kind=small}
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
AI Predicts Tumor-Killing Cells with High Accuracy
Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read morePathology
view channel
Groundbreaking CRISPR Screen Technology Rapidly Determines Disease Mechanism from Tissues
Thanks to over a decade of advancements in human genetics, scientists have compiled extensive lists of genetic variations linked to a wide array of human diseases. However, understanding how a gene contributes... Read more
New AI Tool Classifies Brain Tumors More Quickly and Accurately
Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
